A Study of Treatment Delivery Preference In People With Kidney Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
The purpose of this study is to see if people prefer immunotherapy treatment for kidney cancer delivered intravenously or subcutaneously and if it is practical for participants to receive labs at home and have a video (telehealth) visit with their doctor prior to their day of treatment.
Epistemonikos ID: 0007b78769223e095c23e552cabfc33e9832bd94
First added on: Oct 14, 2026